Objective: Capillary recruitment is impaired in obesity (OB), possibly worsening glucose and insulin availability to target organs. In this study, we investigated whether functional microvascular parameters were correlated with clinical-anthropometrical data and whether these parameters would influence OB-related metabolic disorders, especially glucose homeostasis, in young overweight (OW)/obese women. Design: Cross-sectional clinical study of microvascular reactivity in young OW/obese women. Subjects and methods: A total of 10 lean (23.1 ± 3.2 years, body mass index (BMI) 22.3 ± 1.6 kg m À2 ) and 42 OW/obese (24.9±3.5 years; BMI 34.5±5.7 (25.7-46.5) kg m À2 ) sedentary non-smoking women were evaluated. Lipid profile, fasting plasma glucose (PG), post-load PG (75 g-2 h), insulin, C-reactive protein, HOMA-IR (homeostasis model assessment for insulin resistance) index and anthropometric variables (weight, BMI, waist and hip circumferences, waist-to-hip ratio and blood pressure (BP)) were determined. Functional microvascular parameters (functional capillary density, red blood cell velocity at baseline and peak (RBCV max ), and time taken to reach RBCV max (TRBCV max ) during post-occlusive reactive hyperemia after 1 min arterial occlusion) were evaluated by nailfold videocapillaroscopy. Results: The time taken to reach RBCV max was significantly longer in OW/obese patients compared with control subjects (8.6±2.4 versus 5.7±1.1 s, Po0.001), and its delay was directly associated with adiposity levels, systolic BP and insulin resistance, and inversely related to high-density lipoprotein-cholesterol. Post-load PG could be correlated with TRBCV max (R ¼ 0.48, Po0.05) and RBCV max (R ¼ À0.29, Po0.05), and it was influenced by weight, waist circumference and TRBCV max (adjusted R 2 ¼ 24%) as well. Conclusions: In the investigated group of young OW/obese women, the direct correlation between post-load PG and TRBCV max links microvascular parameters with metabolic variables and suggests a key role for microcirculation in OB-related metabolic disorders.
Introduction
Overweight (OW) and obesity (OB) are becoming epidemic. 1, 2 Excessive accumulation of corporal adiposity results at least in part from the interaction between genetic predisposition and environment that finally establishes the attained body weight. 3 This excessive accumulation of adiposity is the background for most cardiovascular diseases, insulin resistance (IR) and type 2 diabetes mellitus. Independently of age, large vessel function is impaired, as seen in obese children predisposed to elevated cardiovascular risk at adulthood, 4 even when OB was confined to childhood. 5, 6 It is known that young obese adults already show aortic stiffness, 7 but the extent of microvascular damage at early ages and its relationships with glucose tolerance, insulin sensitivity and cardiovascular risk factors remain to be explored. Obesity-associated microvascular dysfunction (MD) may contribute to diseases caused by microangiopathy, such as nephropathy 8 and heart failure, 9 and it has been postulated that MD participates in IR development by limiting glucose and insulin delivery to muscle cells. 10 Hence, at microcirculation, a physiological dose of insulin could promote capillary recruitment and therefore enhance the access of glucose and insulin itself to target organs. Experimentally, it has been shown that graded occlusion of perfused rat muscle vasculature markedly impaired insulin delivery, insulin-mediated Akt phosphorylation and glucose uptake, suggesting a pre-receptor defect in the insulin signaling pathway. 11 Although not yet fully established in a clinical setting, endothelial and MDs, characterized by decreased responses to endothelial-derived relaxing factors (essentially, but not only, nitric oxide) and alterations of hemodynamic parameters such as the number of perfused capillaries and baseline red blood cell velocity, respectively, have been hypothesized as primary causes of IR. [12] [13] [14] [15] In type 2 diabetes mellitus, MD has been well characterized in the coronary bed 16 and the skin, 17 but in the young uncomplicated OW/obese persons, the extent of microvascular damage, tested by a non-invasive method, namely, the nailfold videocapillaroscopy, and its interrelationship with clinical-anthropometrical-laboratorial parameters remains to be determined. In this investigation, we compared the skin microvascular function at rest and during post-occlusive reactive hyperemia (PORH) after a 1 min arterial occlusion of lean or OW/obese young sedentary non-smoking normoglycemic women and evaluated whether the observed alterations were related to cardiovascular risk factors, indirect markers of IR and glucose homeostasis. ) were selected. After physical examination and obtaining consent to participate in the study, they proceeded to a 75-g oral anhydrous glucose tolerance test (fasting and 2 h), lipid profile, C-reactive protein and insulin determinations after a 10-12 h fast. Glucose tolerance was defined according to American Diabetes Association criteria. 18 We also invited 10 lean age-controlled non-smoking ). Main exclusion criteria were pregnancy, known history of type 2 diabetes mellitus and/or hypertension, smoking, major illnesses, a history of previous myocardial infarction or angina pectoris, hypogonadism and triglyceride levels above 600 mg per 100 ml. Evaluated subjects were not using drugs and neither were they under treatment for any disease.
Patients and methods

Patients
Microvascular function assessment
Nailfold videocapillaroscopy was carried out and analyzed according to a standardized, well-validated methodology 19, 20 on the fourth finger of the left hand. Functional capillary density, the number of capillaries/mm 2 with flowing red blood cells, was evaluated at Â 250 magnification and by dividing an area of 3 mm of the distal row of capillaries into three different areas (intra-assay coefficient of variation ¼ 5.5 ± 2.5%). Red blood cell velocity (RBCV) at rest, its highest value after 1 min arterial occlusion (RBCV max ) and the time taken to reach it (TRBCV max ) were measured, at a final magnification of Â 680, before and during the PORH response. Before RBCV assessment on an individual capillary loop, a pressure cuff (1 cm wide) was placed around the proximal phalanx of the fourth finger and connected to a mercury manometer. Basal RBCV was measured thrice and intra-assay coefficient of variation was 17.1%. During PORH, each variable was tested once. Nailfold videocapillaroscopy was repeated on nine subjects on different days and inter-assay coefficient of variation (IECV) ranged from 2.0 to 9.0% between all the functional parameters tested.
Laboratory analysis
All laboratory measurements were performed in duplicate after a 10-12 h fast using an automated method (Modular Analytics E 170 and P, Roche, Basel, Switzerland). Fasting plasma glucose (PG), total cholesterol, triglycerides and high-density lipoprotein-cholesterol were measured by enzyme-colorimetric GOD-PAP (IECV ¼ 1.09%), enzymatic GPO-PAP (IECV ¼ 2.93%), enzymatic GPO-PAP (IECV ¼ 1.29%) and enzyme-colorimetric without pretreatment (IECV ¼ 3.23%), respectively. Plasma low-density lipoprotein-cholesterol was calculated according to the Friedwald equation. C-reactive protein was measured by immunoturbidimetry (IECV ¼ 8%). Serum insulin levels were analyzed by electrochemiluminescence (IECV ¼ 10.6%). Homeostasis model assessment for insulin resistance (HOMA-IR) was calculated according to fasting serum insulin (mUI ml
Statistical analysis Data are expressed as mean ± s.d. followed by an age-adjusted analysis. Comparisons between two groups were performed
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LG Kraemer-Aguiar et al by the Mann-Whitney U-test and between three or more groups by Kruskal-Wallis ANOVA (analysis of variance) followed by post hoc Dunn's test. Partial correlation was used to investigate associations by Spearman's rank order test in the pooled group; correlations were retested by adjusting them for BMI and for normal glucose tolerance. TRBCV max was established as the main microvascular variable able to discriminate between groups (see Results).
Multiple regression analysis was performed to evaluate the possible associations between the normal distributed clinical-anthropometrical-laboratorial variables. A multiple regression analysis was used to test whether the observed associations between normal distributed clinical-anthropometrical-aboratorial data and TRBCV max remained when allowing TRBCV max and post-load PG, after adjustment for normal glucose tolerance in the pooled group (models 1 and 3) and in OW/obese women (models 2 and 4). Twotailed P-valuep0.05 was considered to be statistically significant.
Results Table 1 shows the clinical-anthropometrical-laboratorial differences between controls and OW/obese young women. After post-load PG results, some OW/obese women were diagnosed as glucose intolerant (n ¼ 3) or diabetic (n ¼ 1) and were treated. Functional capillary density, RBCV and RBCV max were not different between groups, but young OW/obese women had longer TRBCV max compared with controls (8.6 ± 2.4 versus 5.7 ± 1.1 s, Po0.001FFigure 1a), which was kept unchanged after adjustment for normal glucose tolerance (n ¼ 38) (8.4±2.4 versus 5.7±1.1 s, Po0.001FFigure 1b). Overweight/obese women were reclassified, according to adiposity (BMI levels), into three new groups: OW (n ¼ 10), obese (n ¼ 16) and severely obese (n ¼ 16). Comparing these latter groups with controls, there were differences between them in weight (Po0.001), BMI (Po0.001), waist circumference (Po0.001), hip circumference (Po0.001), waist-to-hip ratio (WHR) (Po0.001), systolic BP (Po0.001), insulin levels (Po0.001), HOMA-IR (Po0.001) and highdensity lipoprotein-cholesterol (Po0.001). Considering the microvascular parameters, only TRBCV max (Po0.001) was still different among the groups. Post hoc analysis did not show any difference in clinical-anthropometrical-laboratorial parameters, and in TRBCV max between controls and OWs or between the latter and the obese women, but the other individual differences still remained (Table 2) .
At baseline, functional capillary density and RBCV did not correlate with any clinical-anthropometrical-laboratorial data in the pooled group (n ¼ 52), but during PORH, several correlations became possible. In the studied group, RBCV max was inversely correlated with waist circumference (R ¼ À0. 30 Multiple regression analysis with normally distributed variables was used to test which clinical variable(s) could influence TRBCV max . In normoglycemic conditions, Table 3 shows that for the pooled group (model 1) or when only the OW/obese were considered (model 2), post-load PG, HOMA-IR, weight and waist circumference influenced microvascular responses during PORH. Considering the fact that post-load PG was highly correlated with the functional microvascular parameters tested and that TRBCV max was the only parameter that really discriminated controls from patients, it was investigated whether the level of post-load PG could also be 
Discussion
Microvascular dysfunction has already been described in OB, 22 first-degree relatives of diabetic 23 and hypertensive patients, 24 polycystic ovary syndrome 25 and type 2 diabetes mellitus 17 using different methods. Our data confirmed that OW/obese, sedentary, non-smoking and normoglycemic 
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LG Kraemer-Aguiar et al young women have MD and, more importantly, that MD could be correlated with many clinical indexes associated with OB-related metabolic disorders and IR. Using statistical methods, it was possible to show that MD influenced the post-load PG level and that, together with waist circumference and weight, it was responsible for 24% of the observed variation. We have previously shown that older (18-50 years) metabolic syndrome normoglycemic OW/obese subjects have altered microvascular morphology and function at rest and during PORH. 20 In the present investigation in which only younger women, during the fertile period, with excessive adiposity were tested, MD could be detected exclusively during PORH. We have formerly hypothesized 20 that being OW, but with metabolic syndrome, could be sufficient to alter the microcirculation. However, in this study, no significant difference between controls and OWs or between OWs and obese ones could be observed. Age differences in reported studies could account for observed discrepancies. 26 Once again, a continuous increase in TRBCV max in relation to adiposity degree seemed to occur. Post-occlusive reactive hyperemia, usually used to induce capillary recruitment, is thought to be determined at the level of small arterioles 27 and to be independent of the autonomic nervous system. 28 After the onset of reperfusion, there is a sharp rise in blood flow followed by a gradual return to its baseline level, influenced by the accumulation of vasodilator metabolites (including nitric oxide) and the formation of reactive oxygen species, normally washed out or destroyed by circulating blood and smooth muscle cell reactivity. During reperfusion, the myogenic response, owing to the rapid stretch of microvascular smooth muscle cells, is responsible, at least partially, for the return of blood flow to its baseline values. The role of endothelium in modulating the myogenic response is still controversial. 29 Considering the fact that not all the microvascular parameters studied, except TRBCV max , differed significantly among the observed groups, it is possible to propose that the balance between the production of, or response to, vasodilators/vasoconstrictors is deranged.
Resting human skin blood flow in a thermoneutral environment is B250 ml min À1 , 30 but in states such as hyperthermia, it can increase several folds. Overall, hemodynamics are partially dependent on how much blood flow and volume are distributed to the skin. 31 The increased metabolic demand imposed by the expanded adipose tissue and the augmented fat-free mass in OB results in hyperdynamic circulation with increased blood volume. 32 It is already known that, in resting states, cardiac output is often higher, whereas ventricular systolic function remains normal in uncomplicated OB. 33 Therefore, one might hypothesize that the existence of a longer TRBCV max ultimately reflects a prolongation of refill time because of the greater tissue mass.
It is possible to consider that more blood vessels to refill in OW/obese women would require a longer time to reestablish blood flow. In our study, considering TRBCV max as a good index of microvascular function, we noticed that longer TRBCV max occurred mainly in patients with increased systolic BP, adiposity, post-load PG (even considering a normoglycemic range), waist and hip circumferences and WHR, and lower levels of high-density lipoprotein-cholesterol and insulin sensitivity measured by indirect markers (insulin and HOMA-IR). Physiologically, it has been proposed that insulin, by reducing the pre-capillary arteriolar tone and/or altering the arteriolar vasomotion, redirects blood flow from non-nutritive to nutritive capillaries, increasing the number of perfused capillaries and enhancing the access of insulin and glucose to a greater number of muscle cells. Cellular defects in insulin signaling pathways 34 and microvascular and endothelial dysfunctions have been described and/or hypothesized as causes of IR. [12] [13] [14] [15] Results from experimental and human studies have suggested that insulin-mediated changes in muscle perfusion can modulate insulin-mediated glucose uptake. 11, 35 The action of insulin, also seen in the skin, 36 can favor insulin itself and glucose availability to cells. MD seems to be inversely associated with insulin sensitivity in subjects with fasting hyperglycemia. 37 In addition, microvascular function could be related to insulin sensitivity and BP in healthy 38 and hypertensive subjects. 39 To our knowledge, our findings are the first to show the influence of microvascular function on post-load PG levels in normoglycemic conditions, related to excessive adiposity. During physiological hyperinsulinemia, capillary recruitment has been reported in the skin of healthy volunteers, 36 and intramuscular microvascular flow increased in obese patients, 40 confirming the microvascular effects of physio- 
LG Kraemer-Aguiar et al logical doses of insulin. On the other hand, decreased insulin sensitivity has been associated with an impairment of microvascular function 22 and a decrease of the skin microvascular vasomotion. 41 RBCV max and TRBCV max should be viewed as indirect measurements of capillary recruitment, as normal values during PORH result in increased microflow and impaired ones in lower microflow with reduced blood distribution level, leading to a decrease of the surface area available for insulin/cell interaction. Our data support this hypothesis as indirect markers of insulin sensitivity, such as insulin level and HOMA-IR, were directly associated with longer TRBCV max .
The limitations of our study warrant mention. Our crosssectional design does not allow inferences such as causal relationships, and although OW/obese women had MD during PORH, we could not show that OW by itself leads to MD, possibly because of the small sample size. Unfortunately, the skin microcirculation has its own peculiarities and does not entirely express what happens in insulinsensitive tissues related to glucose tolerance, mainly skeletal muscle. However, in hypertensive subjects, a concomitant progressive decrease in vasodilation from low to high BP, in both the muscle and the skin vessels, has been shown. 42 In addition, reinforcing this concomitance, we have previously reported improvements in the skin microvascular function 19 and in forearm endothelial microvascular flow reactivity 43 with an insulin-sensitizing agent given to metabolic syndrome normoglycemic subjects. We should also emphasize that HOMA-IR and insulin levels have limited value 44 to characterize states of IR. In summary, our results show that young OW/obese women have MD and that it could be associated with OBrelated metabolic disorders. The direct correlation between post-load PG and TRBCV max in this group links microvascular parameters with metabolic derangements and suggests a key role for microcirculation in the pathophysiological process.
